GlassScriptPhysician profile
Agastin Michael
NPI 1396894671
$3,026.29
in general payments reported to CMS, 2019-2025
11 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what 81% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2021: $250 · 2022: $141 · 2023: $611 · 2024: $619 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,386.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,208.41 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $131.37 | 2024 | |
| Allergan, INC. | $128.03 | 2019 | |
| Qol Medical, LLC | $125.00 | 2025 | Sucraid |
| Idorsia Pharmaceuticals US INC | $122.91 | 2023 | Quviviq |
| Pfizer INC. | $120.45 | 2019 | |
| Mannkind Corporation | $49.53 | 2022-2023 | Afrezza |
| Exact Sciences Corporation | $49.39 | 2023-2025 | Cologuard Collection Kit |
| Electromed, INC. | $44.58 | 2025 | Smartvest |
| Scpharmaceuticals INC. | $27.49 | 2025 | |
| Inspire Medical Systems, INC. | $19.13 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agastin Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.